STRYKER CORP is 100.7x more valuable than KESTRA MEDICAL TECHNOLOGIES, LTD. by market capitalization ($118.40 B vs $1.18 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | KMTS | SYK |
|---|---|---|
| Market cap | $1.18 B | $118.40 B |
| US-listed rank | #2530 | #130 |
| Revenue (latest FY) | $59.81M | $25.12B |
| Net income (latest FY) | -$113.81M | $3.25B |
| Net margin | -190.3% | 12.9% |
| P/E (trailing FY) | - | 36.5 |
| SEC filings | 105 | 1,000 |
STRYKER CORP is 100.7x more valuable than KESTRA MEDICAL TECHNOLOGIES, LTD. by market capitalization ($118.40 B vs $1.18 B).
In their latest fiscal years, KESTRA MEDICAL TECHNOLOGIES, LTD. reported $59.81M in revenue while STRYKER CORP reported $25.12B.
Full pages: KESTRA MEDICAL TECHNOLOGIES, LTD. and STRYKER CORP, or browse the full rankings.